| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |